Wednesday, November 19, 2008

ADHD drugs - latest news

There remains considerable controversy over the effectiveness and ethics of prescribing medication to children with Attention Deficit Hyperactivity Disorder (ADHD). The U.S. Food and Drug Administration has approved a 30-minute onset of action for a drug called Focalin XR which will allow the manufacturers, Novartis, to claim that the drug takes effect within this time. The move is based on clinical data, including a study of 86 children aged between 6 and 12.

You can find out more about this story at

No comments: